|
31.1.2022 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
C 50/1 |
Sommarju ta’ deċiżjonijiet tal-Unjoni Ewropea dwar l-awtorizzazzjonijiet għat-tqegħid fis-suq tal-prodotti mediċinali mill-1 ta’ Diċembru 2021 sal-31 ta’ Diċembru 2021
(Ippubblikat skont l-Artikolu 13 jew l-Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill (1))
(2022/C 50/01)
— Ħruġ ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta’ notifika |
||
|
9.12.2021 |
Cibinqo |
abrocitinib |
|
EU/1/21/1593 |
Pillola miksija b’rita |
D11AH |
10.12.2021 |
||
|
9.12.2021 |
Rybrevant |
amivantamab |
|
EU/1/21/1594 |
Konċentrat għal soluzzjoni għal infużjoni |
L01FX18 |
10.12.2021 |
||
|
9.12.2021 |
Sitagliptin SUN |
sitagliptin fumarate |
|
EU/1/21/1598 |
Pillola miksija b’rita |
A10BH01 |
15.12.2021 |
||
|
13.12.2021 |
ASPAVELI |
pegcetakoplanas |
|
EU/1/21/1595 |
Soluzzjoni għal infużjoni |
L04AA54 |
14.12.2021 |
||
|
13.12.2021 |
Vaxneuvance |
Vaċċin tal-polysaccharide pnewmokokkali konjugat (15-il valent, adsorbit) |
|
EU/1/21/1591 |
Suspensjoni għall-injezzjoni |
J07AL |
14.12.2021 |
||
|
17.12.2021 |
Xevudy |
sotrovimab |
|
EU/1/21/1562 |
Konċentrat għal soluzzjoni għal infużjoni |
Pending |
17.12.2021 |
||
|
20.12.2021 |
Nuvaxovid |
Vaċċin ta’ COVID-19 (rikombinanti, b’aġġuvanti) |
|
EU/1/21/1618 |
dispersjoni għall-injezzjoni |
J07BX03 |
20.12.2021 |
— Modifika ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
2.12.2021 |
Cimzia |
|
EU/1/09/544 |
3.12.2021 |
||
|
2.12.2021 |
Ebilfumin |
|
EU/1/14/915 |
7.12.2021 |
||
|
2.12.2021 |
Ivozall |
|
EU/1/19/1396 |
7.12.2021 |
||
|
2.12.2021 |
Kaletra |
|
EU/1/01/172 |
3.12.2021 |
||
|
2.12.2021 |
Revinty Ellipta |
|
EU/1/14/929 |
3.12.2021 |
||
|
3.12.2021 |
Kiovig |
|
EU/1/05/329 |
6.12.2021 |
||
|
3.12.2021 |
Lojuxta |
|
EU/1/13/851 |
15.12.2021 |
||
|
3.12.2021 |
Naglazyme |
|
EU/1/05/324 |
11.1.2022 |
||
|
3.12.2021 |
Ocrevus |
|
EU/1/17/1231 |
6.12.2021 |
||
|
3.12.2021 |
Polivy |
|
EU/1/19/1388 |
7.12.2021 |
||
|
3.12.2021 |
Xagrid |
|
EU/1/04/295 |
6.12.2021 |
||
|
6.12.2021 |
RoActemra |
|
EU/1/08/492 |
7.12.2021 |
||
|
7.12.2021 |
Comirnaty |
|
EU/1/20/1528 |
7.12.2021 |
||
|
8.12.2021 |
Spikevax |
|
EU/1/20/1507 |
8.12.2021 |
||
|
9.12.2021 |
ADCETRIS |
|
EU/1/12/794 |
14.12.2021 |
||
|
9.12.2021 |
AMGEVITA |
|
EU/1/16/1164 |
13.12.2021 |
||
|
9.12.2021 |
Amyvid |
|
EU/1/12/805 |
13.12.2021 |
||
|
9.12.2021 |
Apealea |
|
EU/1/18/1292 |
10.12.2021 |
||
|
9.12.2021 |
Chenodeoxycholic acid Leadiant |
|
EU/1/16/1110 |
10.12.2021 |
||
|
9.12.2021 |
Comirnaty |
|
EU/1/20/1528 |
10.12.2021 |
||
|
9.12.2021 |
Dengvaxia |
|
EU/1/18/1338 |
13.12.2021 |
||
|
9.12.2021 |
Erleada |
|
EU/1/18/1342 |
10.12.2021 |
||
|
9.12.2021 |
Esbriet |
|
EU/1/11/667 |
10.12.2021 |
||
|
9.12.2021 |
Exelon |
|
EU/1/98/066 |
10.12.2021 |
||
|
9.12.2021 |
Holoclar |
|
EU/1/14/987 |
13.12.2021 |
||
|
9.12.2021 |
JETREA |
|
EU/1/13/819 |
10.12.2021 |
||
|
9.12.2021 |
Leganto |
|
EU/1/11/695 |
10.12.2021 |
||
|
9.12.2021 |
Livogiva |
|
EU/1/20/1462 |
13.12.2021 |
||
|
9.12.2021 |
Ogluo |
|
EU/1/20/1523 |
13.12.2021 |
||
|
9.12.2021 |
Pioglitazone Accord |
|
EU/1/11/722 |
10.12.2021 |
||
|
9.12.2021 |
Pradaxa |
|
EU/1/08/442 |
14.12.2021 |
||
|
9.12.2021 |
Roteas |
|
EU/1/16/1152 |
15.12.2021 |
||
|
9.12.2021 |
Stalevo |
|
EU/1/03/260 |
10.12.2021 |
||
|
9.12.2021 |
Thalidomide BMS |
|
EU/1/08/443 |
10.12.2021 |
||
|
9.12.2021 |
Xospata |
|
EU/1/19/1399 |
10.12.2021 |
||
|
9.12.2021 |
ZALTRAP |
|
EU/1/12/814 |
10.12.2021 |
||
|
9.12.2021 |
Zyprexa |
|
EU/1/96/022 |
13.12.2021 |
||
|
9.12.2021 |
Zyprexa Velotab |
|
EU/1/99/125 |
13.12.2021 |
||
|
13.12.2021 |
ADCETRIS |
|
EU/1/12/794 |
14.12.2021 |
||
|
13.12.2021 |
Conbriza |
|
EU/1/09/511 |
14.12.2021 |
||
|
13.12.2021 |
Giotrif |
|
EU/1/13/879 |
14.12.2021 |
||
|
13.12.2021 |
Invanz |
|
EU/1/02/216 |
14.12.2021 |
||
|
13.12.2021 |
Kanuma |
|
EU/1/15/1033 |
14.12.2021 |
||
|
13.12.2021 |
Kinzalmono |
|
EU/1/98/091 |
14.12.2021 |
||
|
13.12.2021 |
Mycophenolate mofetil Teva |
|
EU/1/07/439 |
14.12.2021 |
||
|
13.12.2021 |
Neulasta |
|
EU/1/02/227 |
15.12.2021 |
||
|
13.12.2021 |
Neuraceq |
|
EU/1/13/906 |
15.12.2021 |
||
|
13.12.2021 |
NULOJIX |
|
EU/1/11/694 |
14.12.2021 |
||
|
13.12.2021 |
Pramipexole Accord |
|
EU/1/11/728 |
16.12.2021 |
||
|
13.12.2021 |
Pramipexole Teva |
|
EU/1/08/490 |
17.12.2021 |
||
|
13.12.2021 |
Rapiscan |
|
EU/1/10/643 |
15.12.2021 |
||
|
13.12.2021 |
Rebif |
|
EU/1/98/063 |
17.12.2021 |
||
|
13.12.2021 |
Rivastigmine Sandoz |
|
EU/1/09/599 |
15.12.2021 |
||
|
13.12.2021 |
Thalidomide BMS |
|
EU/1/08/443 |
14.12.2021 |
||
|
13.12.2021 |
Xofigo |
|
EU/1/13/873 |
15.12.2021 |
||
|
16.12.2021 |
Ceprotin |
|
EU/1/01/190 |
17.12.2021 |
||
|
16.12.2021 |
Cinacalcet Accordpharma |
|
EU/1/20/1429 |
17.12.2021 |
||
|
16.12.2021 |
Clopidogrel Krka d.d. |
|
EU/1/09/562 |
20.12.2021 |
||
|
16.12.2021 |
Clopidogrel Zentiva |
|
EU/1/08/465 |
23.12.2021 |
||
|
16.12.2021 |
COVID-19 Vaccine Janssen |
|
EU/1/20/1525 |
16.12.2021 |
||
|
16.12.2021 |
Dexdor |
|
EU/1/11/718 |
19.12.2021 |
||
|
16.12.2021 |
Grepid |
|
EU/1/09/535 |
17.12.2021 |
||
|
16.12.2021 |
Herzuma |
|
EU/1/17/1257 |
20.12.2021 |
||
|
16.12.2021 |
Humira |
|
EU/1/03/256 |
17.12.2021 |
||
|
16.12.2021 |
Jyseleca |
|
EU/1/20/1480 |
17.12.2021 |
||
|
16.12.2021 |
KANJINTI |
|
EU/1/18/1281 |
20.12.2021 |
||
|
16.12.2021 |
Retsevmo |
|
EU/1/20/1527 |
20.12.2021 |
||
|
16.12.2021 |
Revestive |
|
EU/1/12/787 |
23.12.2021 |
||
|
16.12.2021 |
Rinvoq |
|
EU/1/19/1404 |
17.12.2021 |
||
|
16.12.2021 |
Sarclisa |
|
EU/1/20/1435 |
17.12.2021 |
||
|
16.12.2021 |
Siklos |
|
EU/1/07/397 |
17.12.2021 |
||
|
16.12.2021 |
Vemlidy |
|
EU/1/16/1154 |
17.12.2021 |
||
|
16.12.2021 |
Vocabria |
|
EU/1/20/1481 |
17.12.2021 |
||
|
16.12.2021 |
Zoely |
|
EU/1/11/690 |
21.12.2021 |
||
|
16.12.2021 |
Zoely |
|
EU/1/11/690 |
21.12.2021 |
||
|
17.12.2021 |
Kineret |
|
EU/1/02/203 |
17.12.2021 |
||
|
20.12.2021 |
Intuniv |
|
EU/1/15/1040 |
21.12.2021 |
||
|
20.12.2021 |
Nitisinone MDK |
|
EU/1/17/1217 |
21.12.2021 |
||
|
20.12.2021 |
PANTOLOC Control |
|
EU/1/09/519 |
21.12.2021 |
||
|
20.12.2021 |
Raloxifene Teva |
|
EU/1/10/627 |
23.12.2021 |
||
|
20.12.2021 |
Selincro |
|
EU/1/12/815 |
21.12.2021 |
||
|
20.12.2021 |
Veklury |
|
EU/1/20/1459 |
20.12.2021 |
||
|
20.12.2021 |
Voriconazole Hikma |
|
EU/1/15/1004 |
4.1.2022 |
— Irtirar ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
13.12.2021 |
Leganto |
|
EU/1/11/695 |
4.1.2022 |
||
|
20.12.2021 |
PANTOLOC Control |
|
EU/1/09/519 |
21.12.2021 |
||
|
20.12.2021 |
Rasilez HCT |
|
EU/1/08/491 |
22.12.2021 |
||
|
20.12.2021 |
Ytracis |
|
EU/1/03/250 |
22.12.2021 |
— Ħruġ ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta’ notifika |
||
|
7.12.2021 |
Imoxat |
imidakloprid/moksidektin |
|
EU/2/21/280 |
Taħlita likwida għall-użu lokalizzat |
QP54AB52 |
9.12.2021 |
||
|
7.12.2021 |
Suiseng Diff/A |
Vaċċin tal-Clostridioides difficile u Clostridium perfringens, inattivat |
|
EU/2/21/278 |
Suspensjoni għall-injezzjoni |
QI09AB12 |
9.12.2021 |
||
|
15.12.2021 |
Zenalpha |
idroklorur tal-medetomidina/idroklorur tal-vatinoksan |
|
EU/2/21/279 |
Soluzzjoni għall-injezzjoni |
QN05CM99 |
16.12.2021 |
— Modifika ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
7.12.2021 |
Circovac |
|
EU/2/07/075 |
9.12.2021 |
||
|
7.12.2021 |
Stronghold Plus |
|
EU/2/16/204 |
13.12.2021 |
||
|
13.12.2021 |
Apoquel |
|
EU/2/13/154 |
15.12.2021 |
||
|
15.12.2021 |
Bravecto Plus |
|
EU/2/18/224 |
16.12.2021 |
||
|
15.12.2021 |
Cardalis |
|
EU/2/12/142 |
16.12.2021 |
||
|
15.12.2021 |
Osurnia |
|
EU/2/14/170 |
16.12.2021 |
||
|
15.12.2021 |
Rabitec |
|
EU/2/17/219 |
16.12.2021 |
Kull min jixtieq jikkonsulta r-rapport ta’ evalwazzjoni pubblika dwar il-prodotti mediċinali kkonċernati u d-deċiżjonijiet marbuta magħhom għandu jikkuntattja lil:
|
European Medicines Agency |
|
Domenico Scarlattilaan 6 |
|
1083 HS Amsterdam |
|
NETHERLANDS |